Arix Bioscience PLC: Transaction in own shares
DJ Transaction in own shares
Arix Bioscience PLC (ARIX)
Transaction in own shares
11-May-2021 / 17:42 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
=
Arix Bioscience plc
Transaction in own shares
LONDON, 11 May 2021: Arix Bioscience plc ( Arix or the Company ) (LSE:ARIX), a global venture capital company focused
on investing in and building breakthrough biotech companies, today announces that it purchased the following number of
its ordinary shares of 0.001 pence each on the London Stock Exchange from Jefferies International Limited as part of a
A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Arix Bioscience PLC: Transaction in own shares
DJ Transaction in own shares
Arix Bioscience PLC (ARIX)
Transaction in own shares
10-May-2021 / 17:21 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
=
Arix Bioscience plc
Transaction in own shares
LONDON, 10 May 2021: Arix Bioscience plc ( Arix or the Company ) (LSE:ARIX), a global venture capital company focused
on investing in and building breakthrough biotech companies, today announces that it purchased the following number of
its ordinary shares of 0.001 pence each on the London Stock Exchange from Jefferies International Limited as part of a
The Board of Maven Income and Growth VCT 5 PLC (the Company) confirms that, on 7 May 2021 and under its Dividend Investment Scheme (DIS), the Company issued and allotted 579,284 new ordinary shares of 10p each (Ordinary Shares) at a price of 37.37p per share which, under the Terms and Conditions of the DIS, is equivalent to the latest announced net asset value per share . As a result, and in accordance with the Financial Conduct Authority s Disclosure, Guidance and Transparency Rules, the Company confirms that its issued share capital as at 7 May 2021 comprises 177,045,809 Ordinary Shares, with each share carrying one voting right. The above figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required, under the Disclosure, Guidance and Transparency Rules, to notify their interest, or a change to their int
A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;